CLASS II Device recall · Reported 10 Jul 2019 · FDA Enforcement Report

EliA RF IgM Well recalled by Phadia Ab

Phadia Ab is recalling EliA RF IgM Well, distributed nationwide in the US. The recall was initiated on 10 May 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI (01) 07333066010854 (17) 200630 (10) 0085 Lot Number - 0085
Quantity recalled30 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1907-2019
FDA event ID
82979
Recalling firm
Phadia Ab, Uppsala, N/A
Classification
Class II
Status
Terminated
Recall initiated
10 May 2019
FDA classified
1 Jul 2019
Reported
10 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

10 May 2019Recall initiated by company
1 Jul 2019Classified by FDA+52 days
10 Jul 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for reporting low assay results

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for the in vitro quantitative measurement of IgM class rheumatoid factor antibodies in human serum and plasma (Li-heparin and EDTA) to aid in the diagnosis of rheumatoid arthritis in conjunction with other laboratory and clinical findings. EliA RF IgM uses the EliA IgM method on the instrument Phadia 100, Phadia 250, Phadia 2500 and Phadia 5000.

Where it was distributed

US Nationwide n the states of NJ, NY, MI, WV, TX including PR

Nationwide MichiganNew JerseyNew YorkPuerto RicoTexasWest Virginia

Questions about this recall

Is EliA RF IgM Well recalled?

Yes. Phadia Ab recalled EliA RF IgM Well on 10 May 2019. The recall is Class II and its status is Terminated. Recall number Z-1907-2019.

Why was it recalled?

Potential for reporting low assay results

Which lots are affected?

UDI (01) 07333066010854 (17) 200630 (10) 0085 Lot Number - 0085

Where was it sold?

US Nationwide n the states of NJ, NY, MI, WV, TX including PR

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Phadia Ab

All 5

Other Test Kits & Diagnostics recalls

All 2,656